Role of Bclaf1 in Promoting Adrenocortical Carcinoma Proliferation: A Study Combining the Use of Bioinformatics and Molecular Events

References

• FassnachtM, AssieG, BaudinE, et al. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(11):1476–1490. doi:10.1016/j.annonc.2020.08.209932861807
   PubMed Web of Science ®Google Scholar
• FassnachtM, DekkersOM, ElseT, et al. European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol. 2018;179(4):G1–G46.30299884
   PubMed Web of Science ®Google Scholar
• BellantoneR, FerranteA, BoscheriniM, et al. Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian national registry for adrenal cortical carcinoma. Surgery. 1997;122(6):1212–1218. doi:10.1016/S0039-6060(97)90229-49426440
   PubMed Web of Science ®Google Scholar
• KerkhofsTM, VerhoevenRH, Van der ZwanJM, et al. Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. Eur J Cancer. 2013;49(11):2579–2586. doi:10.1016/j.ejca.2013.02.03423561851
   PubMed Web of Science ®Google Scholar
• GratianL, PuraJ, DinanM, et al. Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States. Ann Surg Oncol. 2014;21(11):3509–3514. doi:10.1245/s10434-014-3931-z25069860
   PubMed Web of Science ®Google Scholar
• TierneyJF, ChivukulaSV, PoirierJ, et al. National treatment practice for adrenocortical carcinoma: have they changed and have we made any progress?J Clin Endocrinol Metab. 2019;104(12):5948–5956. doi:10.1210/jc.2019-0091531361313
   PubMed Web of Science ®Google Scholar
• TranTB, PostlewaitLM, MaithelSK, et al. Actual 10-year survivors following resection of adrenocortical carcinoma. J Surg Oncol. 2016;114(8):971–976. doi:10.1002/jso.2443927633419
   PubMed Web of Science ®Google Scholar
• SchulickRD, BrennanMF. Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol. 1999;6(8):719–726. doi:10.1007/s10434-999-0719-710622498
   PubMed Web of Science ®Google Scholar
• KebebewE, ReiffE, DuhQY, ClarkOH, McMillanA. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?World J Surg. 2006;30(5):872–878. doi:10.1007/s00268-005-0329-x16680602
   PubMed Web of Science ®Google Scholar
• DingL, BaileyMH, Porta-PardoE, et al. Perspective on oncogenic processes at the end of the beginning of cancer genomics. Cell. 2018;173(2):305–320.e310.29625049
   PubMed Web of Science ®Google Scholar
• LiuJ, LichtenbergT, HoadleyKA, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400–416.e411.29625055
   PubMed Web of Science ®Google Scholar
• LemmensB, HegaratN, AkopyanK, et al. DNA replication determines timing of mitosis by restricting CDK1 and PLK1 activation. Mol Cell. 2018;71(1):117–128.e113.30008317
   PubMed Web of Science ®Google Scholar
• ZhangH, ZhangX, LiX, et al. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer. J Cell Physiol. 2018;234(1):619–631. doi:10.1002/jcp.2681630069972
   PubMed Web of Science ®Google Scholar
• MalumbresM, BarbacidM. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009;9(3):153–166. doi:10.1038/nrc260219238148
   PubMed Web of Science ®Google Scholar
• AsgharU, WitkiewiczAK, TurnerNC, KnudsenES. The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov. 2015;14(2):130–146. doi:10.1038/nrd450425633797
   PubMed Web of Science ®Google Scholar
• VohhodinaJ, BarrosEM, SavageAL, et al. The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export. Nucleic Acids Res. 2017;45(22):12816–12833. doi:10.1093/nar/gkx104629112714
   PubMed Web of Science ®Google Scholar
• WenY, ZhouX, LuM, et al. Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma. Oncogene. 2019;38(11):1845–1859. doi:10.1038/s41388-018-0552-130367150
   PubMed Web of Science ®Google Scholar
• ZhouX, WenY, TianY, et al. Heat shock protein 90α-dependent B-cell-2-associated transcription factor 1 promotes hepatocellular carcinoma proliferation by regulating MYC proto-oncogene c-MYC mRNA stability. Hepatology. 2019;69(4):1564–1581. doi:10.1002/hep.3017230015413
   PubMed Web of Science ®Google Scholar
• RhodesDR, Kalyana-SundaramS, MahavisnoV, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007;9(2):166–180. doi:10.1593/neo.0711217356713
   PubMed Web of Science ®Google Scholar
• TangZ, LiC, KangB, GaoG, LiC, ZhangZ. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx24728407145
   PubMed Web of Science ®Google Scholar
• LangfelderP, HorvathS. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9(1):559. doi:10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• LiaoY, WangJ, JaehnigEJ, ShiZ, ZhangB. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47(W1):W199–W205. doi:10.1093/nar/gkz40131114916
   PubMed Web of Science ®Google Scholar
• WangZ, FanM, CandasD, et al. Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression. Dev Cell. 2014;29(2):217–232. doi:10.1016/j.devcel.2014.03.01224746669
   PubMed Web of Science ®Google Scholar
• XieB, WangS, JiangN, LiJJ. Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance. Cancer Lett. 2019;443:56–66. doi:10.1016/j.canlet.2018.11.01930481564
   PubMed Web of Science ®Google Scholar
• GuoJ, GuY, MaX, et al. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis. J Cell Mol Med. 2020;24(8):4428–4438. doi:10.1111/jcmm.1510232147961
   PubMed Web of Science ®Google Scholar
• KongJ, ZhengJ, CaiJ, et al. A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study. Cancer Commun (Lond). 2019;39(1):80. doi:10.1186/s40880-019-0426-031775884
   PubMed Web of Science ®Google Scholar
• PeyressatreM, PrévelC, PelleranoM, MorrisMC. Targeting cyclin-dependent kinases in human cancers: from small molecules to peptide inhibitors. Cancers (Basel). 2015;7(1):179–237. doi:10.3390/cancers701017925625291
   PubMed Web of Science ®Google Scholar